| Literature DB >> 26481663 |
Emily D Montal1, Ruby Dewi2, Kavita Bhalla3, Lihui Ou2, Bor Jang Hwang2, Ashley E Ropell4, Chris Gordon4, Wan-Ju Liu3, Ralph J DeBerardinis5, Jessica Sudderth5, William Twaddel6, Laszlo G Boros7, Kenneth R Shroyer4, Sekhar Duraisamy8, Ronny Drapkin8, R Scott Powers6, Jason M Rohde9, Matthew B Boxer9, Kwok-Kin Wong10, Geoffrey D Girnun11.
Abstract
Phosphoenolpyruvate carboxykinase (PEPCK) is well known for its role in gluconeogenesis. However, PEPCK is also a key regulator of TCA cycle flux. The TCA cycle integrates glucose, amino acid, and lipid metabolism depending on cellular needs. In addition, biosynthetic pathways crucial to tumor growth require the TCA cycle for the processing of glucose and glutamine derived carbons. We show here an unexpected role for PEPCK in promoting cancer cell proliferation in vitro and in vivo by increasing glucose and glutamine utilization toward anabolic metabolism. Unexpectedly, PEPCK also increased the synthesis of ribose from non-carbohydrate sources, such as glutamine, a phenomenon not previously described. Finally, we show that the effects of PEPCK on glucose metabolism and cell proliferation are in part mediated via activation of mTORC1. Taken together, these data demonstrate a role for PEPCK that links metabolic flux and anabolic pathways to cancer cell proliferation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26481663 PMCID: PMC4656111 DOI: 10.1016/j.molcel.2015.09.025
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970